Intimation Titled 'Technical Committee Approves Final Clinical Trial Stage; Company Targets Regulatory Clearances And Commercial Launch By April 2027'
Filed with BSE · · 3 pages · English
Lord's Mark Industries Limited on 6ix
Earlier from Lord's Mark Industries
- Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Completion Of Phase I Expansion At Silvassa Facility Ahead Of Schedule.
- The Company Has Been Invited To Attend Investor Summit Being Organized By Financial Mindss (A Jaibharti Group Co.)
- Board Meeting Outcome for Outcome Of Board Meeting Held On September 05, 2026 For Approval Of Proposal Of Offer For Sale By The Promoters.
- Reg. 34 (1) Annual Report.
- Announcement under Regulation 30 (LODR)-Newspaper Publication
Later from Lord's Mark Industries
- Intimation Regarding Confirmation And Proposal Received From Promoter, Mr. Sachidanand Hariram Upadhyay For Re-Investment Of Funds Received From Sale Of Equity Shares Of The Company For Medical Device Unit Expansion.
- Intimation Titled 'From An Indian Innovation To A Global Renal-Care Opportunity: Lord'S Mark Industries Takes Its AI-Powered Dialysis Ecosystem Closer To International Markets'
- Closure of Trading Window
- Shareholder Meeting / Postal Ballot-Outcome of AGM
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Follow Lord's Mark Industries into a list and get an email when it puts out news.
Follow Lord's Mark Industries